Alternatives to prasugrel
1 same-class SPL records vs prasugrel - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.
Brand: Effient
About prasugrel
Prasugrel is a drug that helps prevent blood clots. It is used to lower the risk of heart attack, stroke, and blood clots in people with acute coronary syndrome who are undergoing a procedure called percutaneous coronary intervention (PCI).
Used for: Prasugrel helps prevent dangerous blood clots if you have acute coronary syndrome. This includes unstable angina (chest pain) or a heart attack. It is for people who will have a procedure to open blocked arteries, called percutaneous coronary intervention (PCI). Prasugrel can lower your chance of heart attack, stroke, or death.
1 P2Y12 Inhibitor (Antiplatelet) peers (wide set)
prasugrel vs ticagrelor · FAERS reaction fields
FAERS top-reaction field "Dyspnoea" shows the widest count spread between prasugrel and ticagrelor in this extract (3,846-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | prasugrel | ticagrelor |
|---|---|---|
| Myocardial Infarction | 172 | 2,741 |
| Dyspnoea | 106 | 3,952 |
| Acute Myocardial Infarction | 102 | 702 |
| Chest Pain | 90 | 1,445 |
| Nausea | 90 | 836 |
| Drug Interaction | 79 | 929 |
| Dizziness | 78 | 1,223 |
| Fatigue | 71 | 1,525 |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
prasugrel peer mix vs class inventory
Peer mix
0 OTC and 1 Rx SPL records in this peer set (1 total). Class inventory for P2Y12 Inhibitor (Antiplatelet): 2 drugs.
Frequently Asked Questions
What same-class SPL records sit beside prasugrel? ▼
Reading a wide P2Y12 Inhibitor (Antiplatelet) peer set (1 records)
prasugrel (Effient) sits in a wide P2Y12 Inhibitor (Antiplatelet) peer set (1 of 1 class peers shown). Labeled indication field for prasugrel: Prasugrel helps prevent dangerous blood clots if you have acute coronary syndrome.
Top FAERS reaction fields for prasugrel total 919 reports across 10 reactions, set beside ticagrelor. Counts are exposure-weighted submissions, not per-patient risk.
Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for prasugrel: see also the generic vs brand label guide when reading Effient SPL strings.
Read our methodology - how this data is sourced, computed, and verified.